Of note, we found that NLGN3 treatment of OPCs resulted in upregulation of several genes that also increased in expression when human glioma cells were treated with NLGN3 in a previous study demonstrating the functional similarities of Nlgn3 in OPCs and glioma cells (Fig. 6k)2 . The gene discussed is NLGN3; the disease is central nervous system cancer.